LAWRENCE A KENYON
CIK 1230484 · Chief Financial Officer · last filed 2024-09-30
LAWRENCE A KENYON is a Chief Financial Officer who has filed 25 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing shows the insider bought $28.4K of OTLK on Sep 30, 2024. Across all open-market trades the lifetime net is −$460.8K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $176.2K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$176.2K
6
25
-$460.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OTLK | Chief Financial Officer | 5,946 | $1.22 | $7.3K | $28.4K | 2 | 2024-09-30 |
| Outlook Therapeutics, Inc. (OTLKW) Delisted | CEO, Pres, CFO, Treas & Secy | 18,926 | $0.03 | $568 | $36.1K | 9 | 2021-04-20 |
| Outlook Therapeutics, Inc. (ONSIW) Delisted | CEO, Pres, CFO, Treas & Secy | 57,213 | — | — | -$8.8K | 2 | 2018-09-18 |
| Outlook Therapeutics, Inc. (ONSIZ) Delisted | CFO and Secretary | 67,313 | — | — | -$29.6K | 2 | 2017-12-26 |
| PAR PHARMACEUTICAL COMPANIES, INC. (PRX) Delisted | EVP, Chief Financial Officer | 14,337 | — | — | -$540.4K | 6 | 2010-08-04 |
| ACEL | EVP, CFO and Secretary | 12,797 | $13.20 | $168.9K | $53.4K | 2 | 2007-04-12 |
Recent Filings
25 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-09-30 | OTLK | Buy (P) | +5,000 | $28.4K | EDGAR |
| 2024-03-22 | OTLK | Grant (A) | — | $0 | EDGAR |
| 2021-04-20 | Outlook Therapeutics, Inc. (OTLKW) Delisted | Buy (P) | +10,000 | $18.3K | EDGAR |
| 2020-10-05 | Outlook Therapeutics, Inc. (OTLKW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-07-21 | Outlook Therapeutics, Inc. (OTLKW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-03-20 | Outlook Therapeutics, Inc. (OTLKW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-10-15 | Outlook Therapeutics, Inc. (OTLKW) Delisted | Sell (S) | −1,350 | -$2.3K | EDGAR |
| 2019-09-23 | Outlook Therapeutics, Inc. (OTLKW) Delisted | Sell (S) | −1,350 | -$2.3K | EDGAR |
| 2019-09-13 | Outlook Therapeutics, Inc. (OTLKW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-02-19 | Outlook Therapeutics, Inc. (OTLKW) Delisted | Grant (A) | — | $0 | EDGAR |